Kolmar BNH Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 03:22 am
Share
Kolmar BNH Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 657.44 million compared to KRW 250.05 million a year ago. Net income was KRW 14,683.02 million compared to KRW 17,248.49 million a year ago. Basic earnings per share from continuing operations was KRW 497 compared to KRW 584 a year ago. Basic earnings per share was KRW 497 compared to KRW 584 a year ago.
For the six months, sales was KRW 1,247.25 million compared to KRW 516.48 million a year ago. Net income was KRW 27,465.78 million compared to KRW 38,598.84 million a year ago. Basic earnings per share from continuing operations was KRW 930 compared to KRW 1,307 a year ago. Basic earnings per share was KRW 930 compared to KRW 1,307 a year ago.
KolmarBNH Co., Ltd, formerly MIRAE ASSET NO.2 SPECIAL PURPOSE ACQUISITION COMPANY, is a Korea-based company principally engaged in manufacture and distribution of health functional foods, cosmetics and pharmaceuticals. The Company mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The Company also produces cosmetics using natural extracts, and other pharmaceuticals. The Company also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
KOLMAR BNH CO.,LTD. 
